13 reports

Note: ##.

  • Ovarian Cancer
  • bioMerieux S.A.
  • Cepheid
  • Hologic, Inc.
  • Myriad Genetics, Inc.

Infections: Several infections can be treated using polymer drug conjugate systems; examples of these include antiviral, antifungal, antiprotozoan and sepsis.

  • Ovarian Cancer
  • United States
  • Demand
  • Forecast
  • Nektar Therapeutics
  • PIPELINE BY CLOVIS ONCOLOGY INC, H2 2018

IT ACTS BY TARGETING PARP ## AND ## AND TANKYRASE ## AND ##.

  • Oncology
  • Ovarian Cancer
  • Targeted Therapy
  • Therapy
  • AstraZeneca PLC

KCN-## acts by inhibiting hypoxia inducible factor ## alpha (HIF-## alpha) interaction.

  • Ovarian Cancer
  • Therapy
  • United States
  • Product Initiative
  • Cerulean
  • PIPELINE BY ILDONG PHARMACEUTICAL CO LTD, H1 2018
  • PIPELINE BY CLOVIS ONCOLOGY INC, H1 2018

E-## ACTS BY TARGETING PARP ## AND ## AND TANKYRASE ## AND ##.

  • Oncology
  • Ovarian Cancer
  • Therapy
  • United States
  • AstraZeneca PLC
  • PIPELINE BY CLOVIS ONCOLOGY INC, H1 2018
  • PIPELINE BY ILDONG PHARMACEUTICAL CO LTD, H1 2018

The company offers APIs in the therapeutic areas of antibiotic, oncology, cardiovascular, urology, gastrointestinal, antiviral and respiratory, among others.

  • Cancer
  • Ovarian Cancer
  • United States
  • Product Initiative
  • AstraZeneca PLC
  • PIPELINE BY ILDONG PHARMACEUTICAL CO LTD, H2 2018

The company offers APIs in the therapeutic areas of antibiotic, oncology, cardiovascular, urology, gastrointestinal, antiviral and respiratory, among others.

  • Hospital
  • Ovarian Cancer
  • Therapy
  • United States
  • AstraZeneca PLC

Each Unit consists of one Common Share and one Warrant of the Corporation.

  • Monoclonal Antibody
  • Ovarian Cancer
  • Therapy
  • United States
  • Product Initiative

KCN-## acts by inhibiting hypoxia inducible factor ## alpha (HIF-## alpha) interaction.

  • Ovarian Cancer
  • Therapy
  • United States
  • Product Initiative
  • Cerulean
  • PIPELINE BY ILDONG PHARMACEUTICAL CO LTD, H1 2017

IT TARGETS THE ENZYMES POLY (ADP-RIBOSE) POLYMERASE ## AND ## (PARP-## AND PARP-##).

  • Cancer
  • Ovarian Cancer
  • United States
  • Product Initiative
  • AstraZeneca PLC

COADMINISTRATION OF CYCLOPHOSPHAMIDE WITH REOVIRUS IS SAFE, BUT DOES NOT ATTENUATE HOST ANTIVIRAL RESPONSES.

  • Cancer
  • Hospital
  • Ovarian Cancer
  • Therapy
  • Merck & Co., Inc.
  • EPITHELIAL OVARIAN CANCER - PIPELINE BY PHARMA MAR, S.A., H1 2016

Coadministration of cyclophosphamide with reovirus is safe, but does not attenuate host antiviral responses.

  • Cancer
  • Ovarian Cancer
  • United States
  • Product Initiative
  • Merck & Co., Inc.
  • EPITHELIAL OVARIAN CANCER - PIPELINE BY PHARMA MAR SA, H2 2016

HOWEVER, INSIDE A CANCER CELL WITH ONE OR MORE MUTATIONS ON A GROWTH PATHWAY CALLED THE RAS PATHWAY, THERE IS AN ABERRANT ANTIVIRAL RESPONSE THAT IS UNABLE TO PREVENT THE VIRUS FROM REPLICATING.

  • Hospital
  • Immunotherapy
  • Ovarian Cancer
  • Therapy
  • Merck & Co., Inc.